Related Experiment Video
Updated: May 1, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Laboratory testing issues for protein C, protein S, and antithrombin
1Pathology and Laboratory Medicine Services, Oklahoma City VA Medical Center, Oklahoma City, OK, USA; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Genetic defects causing thrombophilia, like those in protein C, protein S, and antithrombin, require accurate lab assays. Understanding assay limitations is crucial for correct genetic status analysis.
Area of Science:
- Clinical laboratory science
- Hematology
- Genetic diagnostics
Background:
- Thrombophilia is a complex condition often manifesting as venous thrombosis.
- Genetic defects in protein C (PC), protein S (PS), and antithrombin (AT) are key contributors to thrombophilia.
- Accurate diagnosis relies on clinical laboratory assays for these components.
Purpose of the Study:
- To review major analytical issues in laboratory assays for PC, PS, and AT.
- To provide recommendations for accurate assaying of PC, PS, and AT in plasma.
- To address pre-analytical and post-analytical factors influencing these assays.
Main Methods:
- Literature review focusing on analytical challenges in thrombophilia testing.
- Analysis of common problems encountered in plasma assays for PC, PS, and AT.
- Synthesis of recommendations for assay validation and implementation.
Main Results:
- Identified significant analytical interferences and limitations in current PC, PS, and AT assays.
- Highlighted the impact of pre-analytical (e.g., sample collection) and post-analytical (e.g., result interpretation) factors.
- Provided evidence-based recommendations for improving assay accuracy and reliability.
Conclusions:
- Accurate assessment of thrombophilia requires a thorough understanding of assay limitations.
- Standardized protocols and awareness of pre- and post-analytical variables are essential for reliable genetic testing.
- Improved assay methodologies and quality control are critical for patient management.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pneumonia III: Complications and Assessment

